Detection and surveillance of antimicrobial resistance among enteric bacteria from raw retail meat and seafood in Iowa: A NARMS Retail Food Surveillance Project
Project Number5U01FD007136-02
Contact PI/Project LeaderSAHIN, ORHAN
Awardee OrganizationIOWA STATE UNIVERSITY
Description
Abstract Text
Project Summary/Abstract
Detection and surveillance of antimicrobial resistance among enteric bacteria from raw
retail meat and seafood in Iowa: A NARMS Retail Food Surveillance Project
Antimicrobial resistance (AMR) is a major health threat affecting the well-being of
humans, animals, and the environment worldwide. Robust and comprehensive surveillance
systems emphasizing the “One Health” approach are necessary for effectively combatting AMR.
In the United States, the retail arm of the National Antimicrobial Resistance Monitoring System
(NARMS) under the Food and Drug Administration, Center for Veterinary Medicine (FDA-
CVM) performs surveillance of AMR in select enteric bacteria (non-typhoidal Salmonella,
Campylobacter, Enterococcus and Escherichia coli) from retail raw meats (chicken, ground
turkey and beef, and ground/chop pork) in 18 states. Recently, surveillance of AMR in retail
seafood (tilapia, shrimp, salmon) for select bacteria (Vibrio, Aeromonas, E. coli, Enterococcus,
carbapenemase-producing Enterobacteriaciae) has also been started in at least 8 states. The
NARMS program has contributed significantly to monitoring the sources and trends of AMR in
the food chain. To enhance the effort on combating AMR, FDA launched a cooperative
agreement program to expand the NARMS surveillance network throughout the U.S in 2016.
Under the initiative, Iowa State University (ISU) became a NARMS network laboratory in late
2016. Since then, the ISU site has contributed substantially to strengthening the capacity and
effectiveness of the national AMR surveillance program in retail food. In this application, we
propose to continue the collaborative partnership with NARMS to address the updated goals of
the Retail Food Surveillance Program as described in FOA PAR-20-124 “NARMS Cooperative
Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food
Specimens”. Specifically, we will continue to collect and process raw meat samples and seafood
samples from grocery stores in Iowa and culture them for isolation of bacteria of interest as
defined by NARMS, and ship the isolates to FDA on a monthly basis. In addition, we will
continue to perform whole-genome sequencing of Salmonella, Campylobacter and E. coli
isolates from the meat samples and share the sequences with FDA via GenomeTrakr. This
application is built on existing experience and is a natural extension of our current effort with
NARMS. Trained personnel and logistic infrastructure required for successful completion of the
planned work are already in place. We strongly believe that ISU’s continued participation in this
collaborative network will contribute significantly to mitigation of AMR in the food chain and
ultimately to enhancement of food safety and public health.
Public Health Relevance Statement
Project Narrative
Antimicrobial resistance (AMR) is a significant public health concern. The National
Antimicrobial Resistance Monitoring System (NARMS) conducts national surveillance of AMR
in retail raw meat and seafood and provides critical information for mitigating AMR. By
continuing our partnership with the NARMS as a network laboratory, our work will enhance
NARMS effort in the surveillance of AMR in retail meat/seafood, and thus will contribute to
mitigation of AMR in the food chain and consequently to enhancement of food safety and public
health.
No Sub Projects information available for 5U01FD007136-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5U01FD007136-02
Patents
No Patents information available for 5U01FD007136-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5U01FD007136-02
Clinical Studies
No Clinical Studies information available for 5U01FD007136-02
News and More
Related News Releases
No news release information available for 5U01FD007136-02
History
No Historical information available for 5U01FD007136-02
Similar Projects
No Similar Projects information available for 5U01FD007136-02